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Abstract
Because of the extreme persistence of per- and polyfluoroalkyl substances (PFASs) and their
associated risks, the Madrid Statement argues for stopping their use where they are deemed
not essential or when safer alternatives exist. To determine when uses of PFASs have an
essential function in modern society, and when they do not, is not an easy task. Here, we: 1)
develop the concept of “essential use” based on an existing approach described in the Montreal
Protocol, 2) apply the concept to various uses of PFASs to determine the feasibility of
elimination or substitution of PFASs in each use category, and 3) outline the challenges for
phasing out uses of PFASs in society. In brief, we developed three distinct categories to
describe the different levels of essentiality of individual uses. A phase-out of many uses of
PFASs can be implemented because they are not necessary for the betterment of society in
terms of health and safety, or because functional alternatives are currently available that can
be substituted into these products or applications. Some specific uses of PFASs would be
considered essential because they provide for vital functions and are currently without
established alternatives. However, this essentiality should not be considered as permanent;
rather, constant efforts are needed to search for alternatives. We provide a description of
several ongoing uses of PFASs and discuss whether these uses are essential or non-essential
according to the three essentiality categories. It is not possible to describe each use case of
PFASs in detail in this single article. For follow-up work, we suggest further refining the
1

assessment of the use cases of PFASs covered here, where necessary, and expanding the
application of this concept to all other uses of PFASs. The concept of essential use can also be
applied in the management of other chemicals, or groups of chemicals, of concern.

Introduction
Per- and polyfluoroalkyl substances (PFASs) are a group of more than 4700 substances1 that
have been produced since the 1940s and used in a broad range of consumer products and
industrial applications2. The multiple uses of PFASs have been well-illustrated by the
FluoroCouncil3. PFASs can be broadly divided into low molecular weight and high molecular
weight (polymeric) substances. The polymeric PFASs can be further subdivided into side-chain
fluorinated polymers, fluoropolymers and perfluoropolyethers2. The review of Buck et al.2 and
the FluoroCouncil website3 should be consulted for a detailed description of the structures,
classes and uses of low and high molecular weight PFASs as that background will not be
provided here.

Since 2000 there have been a number of voluntary industry phase-outs and regulatory actions
to cease the manufacture and use of long-chain perfluoroalkyl acids (PFAAs; defined as
including perfluoroalkane sulfonic acids (PFSAs) with perfluoroalkyl chains containing 6
carbons or more, and perfluoroalkyl carboxylic acids (PFCAs) with perfluoroalkyl chains
containing 7 carbons or more) and their precursors, which can transform in the environment or
within organisms to long-chain PFAAs. The most common replacements for the above defined
long-chain PFAS chemistries are shorter-chain PFASs, e.g. PFAAs with fewer fluorinated
carbons than long-chain PFAAs, and perfluoroether-based substances (PFASs with
perfluoroalkyl segments joined by ether linkages)4. Although some of these replacement PFASs
are less bioaccumulative, they are all similarly highly persistent in the environment as their
predecessors5,6. PFAAs which are considered short-chain and non-bioaccumulative may also
lead to high internal concentrations if people are continuously exposed to high levels. Moreover,
short-chain PFAAs, such as perfluorobutanoic acid (PFBA) and PFHxA, tend to be highly
mobile and to move readily into ground and surface waters once released to the environment
where they can reside for decades to centuries7–10 As a result of their high environmental
persistence, widespread use and release of any PFAS, even polymeric PFASs11, will lead to
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irreversible global contamination and exposure of wildlife and humans, with currently unknown
consequences12–14.

Based on concerns regarding the high persistence of PFASs and the lack of knowledge on
chemical structures, properties, uses, and toxicological profiles of most PFASs currently in use,
it has been argued by more than 200 scientists in the Madrid Statement that the production and
use of PFASs should be limited12. Indeed, in the textile sector, some brand names and retailers
have recognized the problems associated with PFASs and have already taken significant steps
to phase out all uses of PFASs in their consumer products15–18.

It is neither practical nor reasonable to ban all uses of PFASs in one step. Some specific
applications may serve a critical role for which alternatives currently do not exist. However, if
some uses of PFASs are found not to be essential to health, safety or the functioning of today’s
society, they could be eliminated without having to first find functional alternatives providing an
adequate function and performance. Elimination of non-essential uses of PFASs could form a
starting point for a process that leads to a global phase-out (e.g. through the Stockholm
Convention on Persistent Organic Pollutants). To critically evaluate the idea that PFASs are
essential in modern society, the essentiality of PFASs should be carefully tested against the
available evidence for each of their uses. Given the thousands of PFASs on the market and
their many uses, this is a formidable but necessary task. Before proceeding in this task, a
definition of essentiality, or essential use, is needed. If PFASs are considered non-essential in
a given use, then a phase-out of PFASs from that use can be implemented. The aims and
structure of this paper are therefore to: 1) define the concept of essential use or essentiality, 2)
apply the concept to various use categories of PFASs to determine the feasibility of limiting use,
as showcases of the concept, and 3) outline the remaining challenges for phasing out use of
PFASs in society and provide recommendations for further work. It is not our intention to
conduct conclusive assessments for our selected use cases of PFASs on the individual use
level. Follow-up work may be needed to cover each use case in more detail, where necessary,
and to expand the application of the concept to all other uses of PFASs.
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The concept of ‘essential use’
This approach is based on the example of the Montreal Protocol, which phased out the use of
ozone-depleting chlorofluorocarbons except for certain ‘essential’ uses, and which defined the
concept of ‘essential use’ in Decision IV/2519. The two elements of an essential use are that a
use is “necessary for health or safety or for the functioning of society” and that “there are no
available technically and economically feasible alternatives”. To identify uses of PFASs that are
non-essential, we combine the definition of essentiality with several categories of PFAS uses.
Overall, this leads to the three categories summarized in Table 1.
For uses in Category 1 (“non-essential” uses), a phase-out via a ban or restriction of PFASs
can be prepared because these uses are not necessary for the betterment of society in terms
of health, safety and functioning. The technical function of the PFAS (if it has one) in the use
case could be considered “nice to have” (e.g. non-stick frying pans) but it is not essential. In
many cases the “nice to have” function can be fulfilled through substitution with fluorine-free
alternatives. Even where there are no alternatives to PFAS for providing the “nice to have”
function, the use case can be banned or phased out because it is not essential.
Uses in Category 2 (“substitutable” uses) fulfill important functions but are assessed to be nonessential because there are alternatives available that can be substituted into these products
or applications and provide the necessary technical function and performance. It may be
needed to make the alternatives more well-known and more easily available, but there is no
fundamental obstacle to removing PFASs from these uses. Upon increased market uptake, the
costs can be expected to decrease20,21.
Uses in Category 3 (“essential” uses) are considered necessary and currently have no
established alternatives to PFASs that provide the necessary technical function and
performance. Innovative research and development may be needed to identify chemical or
engineering alternatives and to make them technically and economically feasible. By identifying
these opportunities, strong market incentives will be created for industry to develop such
alternatives. In support of this approach research and innovation funding could be made
available specifically for this purpose, and to support start-up companies that intend to develop
and market new alternatives.
4

Table 1. Three essentiality categories to aid the phase out of non-essential uses of
chemicals of concern, exemplified with PFAS uses.

Category

1
“Non-essential”

Definition

PFAS examples

Uses that are not essential for health and safety, Dental floss, water
and the functioning of society. The use of repellent surfer
substances is driven primarily by market shorts, ski waxes
opportunity.

2
“Substitutable”

Uses that have come to be regarded as Most uses of AFFFs,
essential by society because they perform certain waterimportant functions, but where alternatives to resistant textiles.
the substances have now been developed that
have equivalent functionality and adequate
performance, which makes those uses of the
substances no longer essential.

3
“Essential”

Uses considered essential by society because Certain medical
they are necessary for health or safety or other devices,
highly important purposes and for which occupational
alternatives are not yet established.*

protective clothing.

* This essentiality should not be considered permanent; rather, a constant pressure is needed
to search for alternatives in order to move these uses into Category 2 above.
Implementation of this conceptual framework could give rise to ‘grey zones’ where it may not
be straightforward to assign a use to a particular category. For example, a grey zone might
appear between categories 1 and 2 because some uses of PFASs may be considered as niceto-have by some (stain-proof and waterproof outdoor jacket for everyday use) and as necessary
5

by others. Similarly, a grey zone could turn up between categories 2 and 3 because the
availability and performance of alternatives is being debated (e.g. AFFFs used by the military
for extinguishing fuel fires). In order to avoid/minimize such ‘grey zones’ in the implementation
of this conceptual framework, clear criteria and relevant processes need to be pre-defined. This
would require follow up work that is beyond the scope of the present paper.

Technical performance standards may play a role in defining whether the use of PFASs is or is
not considered “essential” in certain cases. Technical performance standards are detailed
specifications concerning how a product should perform in certain circumstances and are often
voluntary. However, they may be used to define whether a product is of sufficient quality to be
placed on the market or to be purchased through public procurement. For example, some
European Union product-related legislation sets so-called “essential requirements” for certain
products and then delegates the task of defining how to meet those requirements to European
standard-setting bodies, such as the European Committee for Standardization (CEN). The
International Standardisation Organization (ISO) and national bodies such as the German
Technischer Überwachungsverein (TÜV) may also set certification requirements that may be
important in the design of the product performance, and how to demonstrate it. The case studies
below provide several examples of how technical standards may affect whether a use of PFASs
is “essential” or not.

Case studies of uses of PFASs
Below we provide descriptions of several ongoing uses of PFASs. We discuss whether the uses
of PFASs are essential or non-essential based on the categorization in Table 1.

Personal care products and cosmetics: PFASs have been found in a range of different
cosmetics and personal care products including hair products, powders, sun blocks, skin
creams22. The fluorinated ingredients in some of the products that have been chemically
analyzed are listed in Schultes et al.22 and include a range of fluorosurfactants and in some
cases the fluoropolymer, polytetrafluoroethylene (PTFE). The use of certain PFASs in these
products may lead to direct human exposure and potential health effects following dermal or
oral uptake. It is not clear whether any technical function provided by the PFASs is truly
necessary. After a recent campaign by a Swedish NGO publicizing the presence of PFASs in
6

certain cosmetics, it was relatively easy for several major retailers and brands of cosmetics to
quickly announce phase outs of PFASs, for example, L’Oréal, H&M, Lumene, The Body Shop,
Isadora and Kicks23. If PFASs in these products were needed for their technical function
(possibly liquid repellency and/or to aid spreading over and into the skin) then drop-in
alternatives appear to have been readily available given the rapid phase out by retailers. The
use of PFASs in personal care products falls under Category 1 in Table 1.

Ski waxes: Whereas most skiers use hydrocarbon-based glide waxes, fluorinated glide waxes
are also available, though much more expensive. The fluorinated waxes are favored by
competitive skiers because they are highly water repellent and result in better glide compared
to hydrocarbon-based waxes. The PFASs used in fluorinated ski waxes are diblock
semifluorinated n-alkanes (SFAs) mixed with normal paraffins2. PFCAs,

including

perfluorooctanoic acid (PFOA), have also been found in fluorinated ski waxes provided as
solids or in powder form24. The presence of SFAs in snow and soil samples from a ski area in
Sweden was recently demonstrated25 and professional ski wax technicians working for the
Swedish national cross-country ski team were shown to be highly exposed to PFCAs26.

From July 2020 onwards, PFOA and related substances (e.g. substances which might form
PFOA in the environment) will be banned in all products sold in the EU, including ski waxes,
due to its recent addition to the REACH Annex XVII list of restricted substances (entry 68). No
essential use of PFAS in ski waxes was found in the restriction process and this use category
is therefore clearly non-essential. Functioning hydrocarbon-based ski waxes were in use before
the fluorinated waxes were introduced. The development of fluorinated waxes was driven by
their exceptional technical performance and market opportunity. Fluorinated waxes provide a
“nice to have” function that is not essential, and therefore this use case falls under Category 1
in Table 1. However, European ski teams are continuing to use fluorinated waxes. The
exception is Norway which in Oct 2018 announced that it has banned the use of fluorinated ski
waxes in U16 categories in national competitions27.

Fire-fighting foams: Class B firefighting foams are formulated to extinguish fires of flammable
liquids, such as liquid hydrocarbon fuels. Those currently available are either; (i) aqueous filmforming foams (AFFF), fluoroprotein foams (FP), or film-forming fluoroprotein foams (FFFP), all
7

of which contain fluorosurfactants (i.e. they contain PFASs) and (ii) fluorine-free Class B foams
(F3) using proprietary mixtures of hydrocarbon or silicone surfactants 28. PFAS-containing
AFFFs historically contained long-chain PFAAs (and their precursors)29, but since 201530 the
foam manufacturers have eliminated long-chain PFAAs (and their precursors) from their
products. Current fluorotelomer-based AFFF formulations contain fluorosurfactants that may
transform to short-chain PFAAs (primarily PFHxA and shorter-chain PFAAs) in the
environment, which are thought to be less bioaccumulative and less toxic than their longerchain predecessors. However, short-chain PFAAs are extremely persistent and mobile, and if
clean-up of soil or water is later needed, it will be extremely expensive and time-consuming, if
at all possible13,31.

Fluorine-free class B foams were first developed in the early 2000s by the 3M Company and
since then many other companies have marketed fluorine-free class B foams28. Many of the
currently available fluorine-free foams meet the standard firefighting performance certifications
applicable to PFAS-containing AFFF and related foams28.

Though some debate continues concerning whether PFAS-containing foams remain necessary
for certain scenarios, e.g., fires at refineries or involving very large fuel tanks, in recent years,
a number of commercial airports, chemical industry facilities, oil and gas platforms, fire brigades
and some national defense forces around the world have switched to using fluorine-free foams
based on demonstrated operational performance in extinguishing fuel fires. However, US
military forces are currently prevented from switching to fluorine-free foams because the
applicable technical standard MIL-F-24385F(SH) – though revised in 2017 to reduce PFOA and
PFOS in AFFFs – still requires fluorinated chemistry in addition to setting a performance-based
requirement. Note that in October 2018, the US Congress enacted a bill32 permitting civilian
airports across the US to use non-fluorinated alternatives. Hydrocarbon-based foams have
been shown to be biodegradable with only localized, short-term problems associated with their
release during extinguishing fires or spillages. The silicone-based foams may contain low
residual amounts of cyclic siloxanes (e.g. decamethylcyclopentasiloxane or D5), which have
been

judged

to

be

persistent

and

bioaccumulative.33

Both

D5

and

D4

(octamethylcyclotetrasiloxane) are listed as Substances of Very High Concern under REACH,
primarily because of their vPvB (very persistent, very bioaccumulative) properties34.
8

In summary, the fluorine-free foams that have been developed and improved since the early
2000s are promising from an operational perspective35–37 and also from an environmental and
human health perspective. Some military maintain that only PFAS-containing AFFF can provide
the necessary performance requirements, particularly in the case of large fuel fires. Because
of ongoing debate, this use category therefore currently falls under Category 2 or 3 in Table 1.

Durable water and stain repellency in textiles: Liquid repellency in textile products can range
from an optional “nice-to-have” property in leisure jeans to an essential protection needed in
occupational protective clothing38. The textile sector often refers to these chemistries as durable
water repellents (DWRs), but the leading market technology repels more than just water. Since
their introduction in the 1950s, the highest level of repellency for both oil/stain and water has
been achieved with side-chain fluorinated polymers. Substitution to ‘short-chain’ side-chain
fluorinated polymers (typically C6 or C4 perfluoroalkyl chains) has taken place in recent years.
However, there is concern regarding the extreme persistence and lack of human health data
for short-chain PFAAs.

A variety of new non-fluorinated DWR alternatives has been developed to create repellent
textile surfaces, with a variety of polymer architectures, including linear polyurethanes, hyperbranched polymers and nanoparticles38. The functional moieties in terms of liquid repellency
consist of either saturated alkyl chains (i.e. hydrocarbons) or polydimethylsiloxane (PDMS)
chemistry (i.e. silicone polymers)38. Although hazards associated with non-fluorinated DWRs
are not yet fully understood, the development of biodegradable alternatives is an important
step. Similar to the silicone-based surfactants used in fire-fighting foams, the silicone-based
DWRs may contain residual amounts of persistent cyclic siloxanes (e.g. D4 and D5).

Non-fluorinated DWRs have been shown to provide high water repellency equal to short-chain
fluorinated polymers and are suitable substitutes for consumer outdoor clothing.39 Indeed, a
number of leading brands already provide water-repellent outdoor jackets marketed as e.g.
“fluorine-free”.

However, in the case of both non-polar and polar liquids with very low surface tension (such as
olive oil or gastric fluid), so far only short-chain fluorinated polymers have been shown to
9

provide effective protection40. Such protection may be important in certain occupational settings
where a specified level of performance is required.

Medical textiles are an example of where technical standards to protect human lives require a
certain performance that may be difficult to meet without the use of PFASs. The European
standard EN 13795 defines how the essential requirements set forth in the EU Medical Devices
Directive (93/42/EEC)41 should be met with respect to surgical gowns, drapes and clean air
suits. Along with setting performance requirements aimed at preventing the transmission of
infectious agents between patients and medical staff, EN 13795 also stipulates the test
methods for evaluating whether the performance requirement is met. Test method EN 20811 42
– resistance to liquid penetration -- measures the pressure at which water will penetrate the
fabric and is used to determine whether the fabric will provide sufficient protection against
contamination from penetration by e.g. bodily fluids. Current non-fluorinated DWRs may not
provide sufficient liquid repellency for non-polar bodily fluids with low surface tension. An
alternative is to use surgical gowns coated with a plastic laminate, which offer sufficient
protection against biological fluids containing potentially harmful viruses and bacteria but may
not be sufficiently breathable for longer operations.

Similarly, performance standards set by the US National Fire Prevention Association for
protective clothing for firefighters and other emergency responders for water repellency,
oil/stain repellency and breathability are currently not possible to meet without fluorinated
chemistry. Other types of occupational clothing, e.g. in the oil and gas sector, may require a
similar combination of water and oil/stain repellency as well as breathability. At least for now,
these uses of PFASs may be considered essential and in Category 3, until effective and safer
alternatives are available.

In summary, non-fluorinated DWRs are available that provide good water repellency (and
certain stain repellency) meeting consumer requirements and expectations for most outdoor
apparel, casual wear, and business attire (Category 2). In some cases, the use of fluorinated
DWRs in textiles is “nice to have” (e.g. water repellent surfer shorts), but is non-essential and
falls under Category 1. Only a few uses of PFAS in textiles, e.g. the occupational protective
clothing market, where repellency of a wider range of liquids as well as breathability are
10

necessary, fall under Category 3 in Table 1. In those cases, innovative solutions are needed to
provide non-fluorinated alternatives.

Food contact materials: Food contact materials (FCMs) cover a range of materials, which at
some stage come into contact with food. This includes (industrial) food production equipment
and machinery, food packaging, and kitchen utensils like non-stick forms and pans. Growing
consumer concern over environmental and health impacts of plastic packaging has led to an
increasing market pressure for alternative packaging, including paper43. This may result in
increasing exposures to PFAS-containing paper-based materials.
The types of fluorochemistry used to protect paper and board have changed over time44. The
most studied use of PFASs in FCMs are the longer-chain perfluoroalkyl moieties44 in paper and
board used in food contact materials, which were phased out by major manufacturers in the
2000s. Current fluorinated paper and board products are largely based on “short-chain”
fluorotelomer-based polymeric products, which are side-chain fluorinated polymers containing
perfluoroalkyl side chains, typically with six perfluorinated carbons44, and poly- and
perfluoropolyethers45–48.

Despite reassurances by the chemical manufacturing industry that short-chain fluorinated
products are safe, there is concern that PFASs will migrate into food and cause harm to human
health44. Non-fluorinated alternatives have subsequently entered the market in recent years.
For example, COOP Denmark A/S, a Danish consumer goods retailer, has succeeded in
completely removing PFAS from all its products since September 201449.

Although the current polymer chemistry used in paper and board in food contact materials is
similar to that used in textiles, paper and board are often made for single use, whereas textiles
(e.g. outdoor jackets) need to be durable over the lifetime of a garment. However, some paper
and board products need to provide repellency to oil for weeks to months (e.g. butter wrappers),
whereas others (e.g. fast food wrappers) only require oil repellency for a matter of minutes. The
substitution strategies for paper and board are therefore different than for DWRs in textiles
given the difference in materials and performance requirements, and may even be different
among food contact applications.
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There are generally two types of barriers against grease or fat for paper and board, a physical
or a chemical barrier44. A physical barrier preventing penetration of a liquid into the paper may
be sufficient in certain types of single use applications. The chemical barrier, which is the
approach used in fluorinated products, repels the grease in the food due to the decreased
surface energy of the paper surface. Two of the most common types of paper that provide a
physical barrier against grease are Natural Greaseproof paper50 and vegetable parchment51,
providing a dense cellulose structure that prevents the grease from soaking into the paper.
There are also various non-fluorinated chemical barriers that can provide similar repellency to
grease as fluorinated repellents, including hydrocarbon- and silicone-based alternatives52. A
third alternative is to add aluminum or plastic coatings to the paper to provide protection53.

In food production, PFASs are mainly used as non-stick fluoropolymer (e.g. PTFE) coatings of
(metal) surfaces to lower friction (which protects the equipment from abrasion), to minimize
adhesion (which allows better cleaning of surfaces), as non-stick/heat/acid resistant
fluoroelastomer membranes on conveyor belts, and as lubricant oils and greases in
machinery54–57. Many of the same uses exist in household kitchen utensils and appliances.
These uses are described in industry patents and commercial materials 54, but the levels and
types of PFASs have been studied only to a limited extent58,59.

Non-stick kitchenware is normally produced by either spraying or rolling layers of PTFE onto
the surface of the kitchenware. One could argue that the non-stick is a “nice to have” function
rather than an essential function given that it is possible to cook food without the non-stick
functionality. If the non-stick coating is considered an essential function in a modern society,
then other possible non-stick coatings are available, including: enamelled iron-, ceramic-, and
anodized aluminium coatings60.

In summary, non-fluorinated alternatives have been historically available for all applications of
paper and board food packaging and the use of fluorinated protective coatings has never been
essential (Category 1). For example, COOP, a major grocery retailer in Denmark, has found
alternatives for all products that previously used PFAS49,61. For non-stick cookware there are
also non-fluorinated non-stick alternatives which work well in households and this is also not
12

an essential function (Category 1). In the food production industry non-fluorinated conveyor
belts, lubricants and greases exist, but it is not clear currently whether functional alternatives to
fluoropolymer protection against abrasion exist (Categories 2 or 3).

Medical devices: Another use of fluoropolymers is as coatings in catheters, stents and needles
to reduce friction and improve clot resistance and to provide protein-resistance in filters, tubing,
o-rings, seals, and gaskets used in kidney dialysis machines and immunodiagnostic
instruments3,54,62. The safety evaluation of these devices for use in humans was discussed by
Henry et al. (2018).63 After review, multiple regulatory agencies have concluded that the use of
PFASs in these products, including on devices implanted into patients’ bodies, does not pose
an appreciable risk because the fluoropolymers are not bioavailable63–65. It is however unclear
whether impurities of fluoropolymer processing aids such as PFOA and HFPO-DA were
included in the regulatory reviews.

In summary, the inclusion of fluoropolymers into medical devices confers several benefits and
does not appear to pose substantial health risks to those who are exposed to these devices
through procedures or who have received implants. However, the production and disposal of
these devices will continue to lead to the release of PFASs into the environment unless steps
are taken to eliminate environmental releases. The use of PFASs in medical devices falls under
Categories 1–3 in Table 1 (depending on specific use). However, due to limited information in
the public domain, it is currently unclear if all medical devices need fluoropolymers or only
certain types of medical devices need fluoropolymers
Pharmaceuticals: There are a wide range of fluorine-containing pharmaceuticals66. Since the
first fluorine-containing drug was approved by the U.S. Food and Drug Administration (FDA) in
1955, nearly 150 fluorinated drugs have reached the market and about 30% of newly approved
drugs contain fluorine constituents including fluoroalkyl groups (a smaller subset can be defined
as PFASs). According to Zhou et al. (2016)66, fluorinated drugs encompass all therapeutic
areas, are structurally diverse, and are among the most-prescribed and/or profitable in the U.S.
pharmaceutical market.
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Fluorination of pharmacological agents is often used to enhance their pharmacological
effectiveness, increase their biological half-life, and improve their bioabsorption66. Some agents
are analogous to the long-chain PFASs, such as several types of artificial blood formulations
and drugs for the lungs of prematurely born children (for example: perfluorooctyl bromide, an
eight-carbon bromine-substituted PFAS67). However, most fluorine-containing pharmaceuticals
have only one or two fluorine atoms. A smaller number of drugs contain one or two
trifluoromethyl groups (-CF3), or the perfluoroalkyl moiety CnF2n+1 as defined by Buck et al.
(2011)2. As these agents become more widely produced, prescribed, and used, disposal of
these fluorinated drugs (e.g. through municipal wastewaters) is likely to lead to increasing
environmental releases of various PFAS. A transformation product of nearly all of the
anesthetics is trifluoroacetic acid (TFA or CF3COOH), which can arise from several metabolic
or atmospheric degradation pathways68 and has been a cause of environmental concern.69–71

In summary, the addition of 1-3 fluorine atoms or trifluoromethyl groups to various
pharmaceutical agents has improved their efficacy, half-lives, and bioabsorption and does not
appear to pose substantial health risks to those who take them, relative to analogous nonfluorinated drugs. However, their production and disposal will continue to lead to the release of
PFASs into the environment unless steps are taken to eliminate environmental releases.
Releases of human metabolic excretion products may pose an additional environmental
concern (contamination of water and greenhouse gases) as these drugs become more widely
used. The uses of –CR2F, -CRF2, and -CF3 groups in pharmaceuticals should not be evaluated
for essentiality as a single group, as specific applications will likely fall under either Categories
2 or 3 in Table 1; there are functional non-PFAS alternatives for some pharmaceutical
applications, whereas for other uses the pharmaceuticals have essential life-saving functions.

Laboratory supplies, equipment and instrumentation: PFAS-containing products, in
particular fluoropolymers, are also ubiquitous in laboratories, laboratory supplies and analytical
instrumentation. Initially this caused major concerns regarding PFAS contamination of
environmental and biological samples during PFAS analysis and maintaining quality control in
PFAS analysis72,73. The PFASs are used because they have high resistance to chemicals and
heat, low surface energy and permeability, which prevents chemicals/analytes from being
adsorbed to the surface and absorbed into the material.
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In the laboratory, there are easily identifiable fluoropolymer (e.g. PTFE) and fluoroelastomerbased products (e.g. Viton). Examples include the use of fluoropolymer-based vials, caps and
tape, and fluoropolymers in the solvent degassers of liquid chromatography (LC) instruments.
Non-PFAS replacements may be available, depending on the purpose. Personal protective
equipment can also contain PFASs, including protective gloves and protective mist/anti-fog
coatings of glass (e.g. PFPE). These applications can in general be substituted without major
loss of functionality or performance; recommendations for PFAS-free alternatives are often
provided as part of guidance to prevent cross-contamination when sampling or analyzing
environmental matrices for PFAS.74–76

As part of field or laboratory collection of particles of different sizes, some filters are made of or
are coated with PFASs to minimize sorption of compounds to the filter itself, such as glass fiber
filters, or ultrafiltration filters. As an alternative plastic filters/vials with a low solid surface energy
can be used (e.g. polypropylene (PP), polytetramethylene oxide (PTME) and polyamide
(nylon))46,77.

More difficult to identify are fluoropolymer and fluoroelastomer seals (o-rings), and
fluoropolymer-based tape within internal components of existing instrumentation. As a result of
advances in analytical instrumentation, in particular ultra high-pressure liquid chromatography
(UHPLC), the use of fluoroelastomers is widespread as seals and membranes and PTFE as
inert surfaces inside analytical instruments and in some cases as tubings. The tubing can be
replaced by polyetheretherketone (PEEK) or stainless steel tubing without a loss of
performance in most applications. Some applications rely on fluorinated solvents (e.g.,
trifluoroethanol) and acids (trifluoroacetic acid, pentafluorobutanoic acids etc.) added to
reversed phase LC-MS solvents, and specialty LC-columns are based on fluorinated materials.
Non-fluorinated alternatives exist for both these uses.

Perfluorpolyether-based lubricants are also used as oils and greases in pumps and equipment;
this can cause laboratory background contamination. Oil-free pumps exist and are reducing the
laboratory background contamination, which is beneficial for both the analyses and workers’
health. To address concerns related to instrument contamination by PFASs, manufacturers
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offer a delay column to keep the instrument-borne PFASs from eluting with target analytes
during the same time window.

For the vast majority of laboratory applications, PFAS alternatives have been used historically
or have been newly developed. Therefore, most applications fall within Categories 1-2 in Table
1, i.e., they are non-essential and replaceable. A small number of current laboratory
applications may fall within Category 3 as being essential and without appropriate alternatives,
and thus further innovation for effective substitution is required.

Perfluorosulfonic membranes: These are fluoroelastomers that exist in many forms and are
used in a wide range of chemical synthesis and separation operations and in analytical
instrumentation. These membranes are often used in processes that displace less efficient
historical methods that use more energy and/or generate hazardous materials and
byproducts78,79. Nafion® (CAS Number 66796-30-3) is the brand name for a perfluorosulfonic
acid membrane from Chemours (formerly DuPont) that consists of a perfluorosulfonic acid
copolymer with pendant sulfonic acid groups. It is stable in strongly oxidizing conditions and
high temperatures. The density of sulfonic acid groups can be controlled during synthesis to
select for variable ion exchange capacity, electrical conductivity, and various mechanical
properties.

One of the earliest principal uses of Nafion was as a membrane in the chlor-alkali process,
which is the large-scale industrial process that uses brine and electricity to produce the common
chemical feedstocks, chlorine gas and sodium hydroxide80. Historically these high-volume
chemical commodities were prepared with brine in either asbestos diaphragm cells or mercury
electrode cells. Both methods generate substantial quantities of hazardous wastes through
either the mining and the fabrication of suitable asbestos membranes or the release of aqueous
and volatile mercury wastes. Use of Nafion copolymer as a membrane in the electrochemical
cell allows for excellent conductance of ions necessary for the process, while maintaining
separation of the two parts of the cell under highly caustic conditions.

Perfluorosulfonic acid membranes are also used in high-efficiency fuel cells where, in one
example, hydrogen and oxygen are pumped into different chambers within a cell that are
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separated by the membrane, giving rise to a continuous supply of electricity for various specialty
applications. Perfluorosulfonic acid membranes are also used as an acid catalyst in a wide
range of chemical conversions leading to decreased energy inputs and higher purity products.

While it can be argued that perfluorosulfonic acid membranes have made many chemical
preparation processes more efficient and cleaner, it is also important to acknowledge that the
impacts from their production and use are still poorly understood. Research at one
fluorochemical production site in Bladen County, North Carolina has documented that Nafionrelated wastes have been released into the nearby Cape Fear River since at least 2012.81
Moreover, the relatively advanced drinking water treatment plant in the city of Wilmington, North
Carolina, has been unable to remove these Nafion-related wastes82,83 giving rise to a situation
where approximately 99% of the residents of Wilmington now have measurable concentrations
of Nafion Byproduct 2 in their blood84. No human health data are currently available for Nafion
Byproduct 2, and the human half-life of this material is likely to be on the order of months to
years83. The production of perfluorosulfonic acid membranes has provided great utility by
improving the efficiency of large-scale chemical syntheses while also reducing the emissions
of other known hazardous byproducts (asbestos and mercury), but the current production
process leads to the release of at least one persistent byproduct with near universal exposure
in a downstream community.

The use of perfluorosulfonic acid membranes is currently judged to be Category 3 (essential)
in the chlor-alkali process. Before the use of Nafion, there were concerns for worker safety and
the environment associated with mercury and asbestos. The use of Nafion as an alternative
was the direct result of the chlor-alkali industry addressing these concerns. In the case of the
use as a proton exchange membrane (PEM) in fuel cells, there are alternatives to
perfluorosulfonic acid membranes85, but these are under development and not used as
commonly as Nafion (Category 2). Although there is a lack of functional alternatives for certain
applications, it is reasonable to insist that emissions of persistent and potentially toxic wastes
from the production and use of perfluorosulfonic acid membranes be quantitatively determined
and minimized as much as possible.
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Discussion
The Montreal Protocol has provided a successful blueprint to assess the essentiality of a class
of widely used persistent chemicals found to have significant human and environmental health
risks. Because of their extreme environmental persistence, and increasing data on their
adverse effects including human health-related endpoints, PFASs are a prime opportunity for
applying a similar approach to protect human health and the environment through the removal
of these chemicals from non-essential uses. Our review of several key uses of PFASs
demonstrates that currently a global phase-out of PFASs will be complicated, but it also
indicates a number of starting points. In particular, different phase-out strategies will be required
for each essentiality category. The essentiality of PFASs in the different use categories, based
on our three categories in Table 1, is summarized in Table 2. Within a few of the larger use
categories (e.g. textiles) certain uses of PFASs appear to be easier to phase out (e.g. leisure
rain jackets) than others (occupational protective clothing) due to different technical
performance requirements.

Table 2: Essentiality of PFASs in selected use categories.
Use

Table 1
Category*

Personal care products including cosmetics

1

Ski waxes

1

Fire-fighting foams (commercial airports)

2

Fire-fighting foams (military)

2 or 3

Apparel (medical: long operations)

3

Apparel (protective clothing oil and gas industry)

3

Apparel (medical: short operations, everyday)

2

Apparel (military: occupational protection)

2 or 3

Waterproof jacket (general use)

2

Easy care clothing

1

Food contact materials
Non-stick kitchenware (fluoropolymers)

1, 2 or 3
1 or 2
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Medical devices (fluoropolymers)
Pharmaceuticals
Laboratory supplies, equipment and instrumentation

1, 2 or 3
2 or 3
1, 2 or 3

Perfluorosulfonic membranes in fuel cells

2

Perfluorosulfonic membranes in chlor-alkali process

3

*Note that the categories in the above table represent the current evaluation and may change
in the future.
Alternatives assessment. Even if PFASs are assessed, according to the criteria in Table 1,
to be non-essential in a particular use, and functional alternatives are available, this is only a
first step to phase out and responsibly substitute PFASs. It cannot be generally assumed that
non-fluorinated alternatives will be less harmful to human health and the environment than the
PFASs they are replacing. The scientific discipline of alternatives assessment has established
processes and best practices for identifying, evaluating, comparing, and selecting safer
alternatives to chemicals of concern based on hazards, performance, and economic viability86–
88.

This process can be applied to PFASs used in material components, finished goods,

manufacturing processes, or technologies. Not all substitutions require direct replacements of
a fluorinated compound with a non-fluorinated alternative (i.e. chemical alternative); a
technological or engineering innovation (i.e. functional alternative) can be equally successful4
and should always be encouraged/prioritized over chemical alternatives. Multiple alternatives
should be assessed for a given PFAS until an acceptable substitution is found. Often, once an
alternative is found for one use case, it may be easily adapted for other use cases of that
chemical as well. In the assessment, once possible non-hazardous alternatives are identified,
it is also important to consider multiple endpoints 89 such as energy use, material use (incl. food
waste, water use, packaging/machinery use and durability), and land-use (e.g. paper vs. plastic
vs. glass), to avoid burden-shifting between different environmental and human impacts.

When considering chemical alternatives for PFASs, the focus should be on the service the
product should deliver. The compound should therefore be evaluated for performance using
the specifications required for the product, as opposed to comparing directly to the PFAS being
replaced. Additionally, the potential for health hazard and potential for exposure – combined,
these elements establish the health risks associated with the alternative – must be considered
for the general public and vulnerable populations. Finally, additional considerations such as
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product longevity, persistence in the environment, and sustainability may be considered.
Currently there are several established frameworks and evaluation metrics available for
conducting alternative assessments86,90. In the absence of a thorough evaluation, regrettable
substitutions can occur.
Challenges and opportunities in chemical regulation. The Madrid Statement12 recommends
limiting the use of PFASs in society. Although all PFASs are highly persistent (or lead to highly
persistent transformation products), many of them do not comply with the usual concerns
considered in international chemical regulation. It can be argued that their extremely high
persistence alone should be cause for regulation and substitution13,14, but the practical
regulatory tools to implement this approach are currently lacking.
Within the context of the EU REACH Regulation, it has been argued91 that the most effective
way of regulating short-chain PFASs (as with the regulation of long-chain PFASs) is to identify
them as Substances of Very High Concern under REACH Article 57, followed by a REACH
Annex XVII restriction. Indeed, the EU has considered (e.g. in the case of the restriction of
PFOA and its related chemicals), and is continuously considering ways to group PFASs in
recognition of the impossibility of regulating more than 4700 PFASs individually.

Another relevant regulatory framework is the UN Stockholm Convention on Persistent Organic
Pollutants, which are similar to the essential-use exemptions under the Montreal Protocol.
Under the Convention, the Conference of the Parties (COP) considers listing new persistent
organic pollutants for elimination (Annex A), or restriction (Annex B), and/or involuntary
production (Annex C) based on a recommendation from the Convention’s Persistent Organic
Pollutants Review Committee (POPRC). The Convention requires that the Conference, “taking
due account of the recommendations of the Committee, including any scientific uncertainty,
shall decide, in a precautionary manner, whether to list the chemical, and specify its related
control measures, in Annexes A, B and/or C” (Art. 8, Para. 9). As part of its deliberation of
whether to list a chemical, the COP also considers whether to allow for any “specific
exemptions” and/or “acceptable purposes”. “Specific exemptions” is time-limited with one
period of five years with the possibility of one extension for another five years, whereas the time
period for the applicability “acceptable purposes” is more open-ended.
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Currently, there is no clear defined criteria for identifying “specific exemptions” and “acceptable
purposes” set in the text of the Stockholm Convention. Such “essential use-like” exemptions
are primarily identified through the work of POPRC on a case-by-case basis. However, the
COP has subsequently adopted detailed criteria for consideration of requests to extend specific
exemptions. For production exemptions, the requesting party must have submitted a
justification for the continuing need for the exemption that establishes that the extension is
necessary for health or safety, or is critical for the functioning of society; included a strategy in
its national implementation plan aimed at phasing out the production for which the extension is
requested as soon as is feasible; taken all feasible measures to minimize the production of the
chemical and to prevent illegal production, human exposure and release into the environment;
and the chemical must be unavailable in sufficient quantity and quality from existing stockpiles.
Finally, in the case of a party with an economy in transition, the party must have requested
technical or financial assistance pursuant to the Convention, in order to phase out as soon as
feasible the production for which the extension is requested (see COP Decision SC-2/3,
“Review process for entries in the Register of Specific Exemptions”92).

We are convinced that having clear legal guidelines for what constitutes an essential use (a
process started in this present work) will benefit the Stockholm Convention and other regulatory
frameworks by supporting clear guidelines for determining how to apply the essential use-like
exemptions, i.e., by balancing costs versus the societal benefits of the use of a substance or
product. A clear definition of essential use ensures that only those applications that are
necessary for health or safety (or other purposes highly important to society as a whole) and
for which non-fluorinated alternatives are not yet available could receive exemptions when
chemicals are listed under the Convention. Further, this approach would protect those uses
that are legitimately deemed essential until appropriate substitutions can be identified.

The way forward. Innovation in the development of alternatives to PFASs is ongoing and many
functional alternatives that provide adequate technical performance have been developed and
put into practice for some use categories. However, in other use categories little innovation is
under way, due to lack of financial or regulatory drivers to change methods/production,
significant technical challenges, lack of awareness of the market opportunities, or the small size
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of the market. Innovation is being encouraged in countries like Denmark (e.g. substitution of
PFASs in textiles) and in Sweden through the availability of government funding for industryacademic partnerships (e.g. the POPFREE project93 to encourage small companies to develop
non-fluorinated alternatives to PFASs). Furthermore, one of the four key areas in ECHA’s 2018
strategy on substitution94 is to ‘Develop coordination and collaboration networks’ between all
stakeholders, ranging from institutions, member states, industry, academia and civil society.

In some cases, the PFASs in a product or use will be determined as the only compound capable
of delivering the required level of performance for that application. In these cases, it is
recognized that immediate phase out will not be feasible. But this assessment is only based on
current technologies. With clear legislative incentives, new technologies will typically be
developed, and consequently PFASs in Category 3 should continue to be reviewed for potential
removal or replacement by new entrants to the market. In fact, use cases identified as Category
3 should be the targets of industry and academic programs to develop innovations that may
succeed in removing or replacing the PFAS with more sustainable functional alternatives. This
system creates a market pressure to be the first to develop new technologies.

Chemical regulation on the other hand progresses slowly compared to product innovation, and
assessment of individual PFASs is not feasible for protecting public health. It is simply unlikely
that society and industry will spend the money and time to generate adequate data to risk
assess >4700 PFAS. Therefore, we strongly recommend a grouping approach be employed,
and for PFASs to be regulated as a group. Since regulation of the many thousands of PFASs
by authorities is likely to be time consuming, it is important for industry (in particular product
designers and manufacturers) to take voluntary measures that will contribute substantially in
reducing the emissions of PFASs and their presence in products. There have already been
several examples of retailers who through private procurement have phased out PFASs from
their supply chains (e.g. IKEA, Lindex, and H&M in Sweden15,17,95, COOP in Denmark61, Vaude
in Germany96, L’Oreal in France97), which in turn puts pressure on chemical manufacturers to
find safer alternatives.

We are convinced that our criteria on essential use can inform and encourage other retailers to
consider phasing out and substituting PFASs in their products. These types of voluntary
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measures will in turn help regulators by demonstrating that functional alternatives exist. When
policy makers face stakeholder groups from both sides, they can use data-driven essentiality
assessments to support their decision making, e.g., to show why certain uses are not necessary
and therefore can be restricted. This will speed up regulatory actions in support of phasing out
non-essential uses of PFASs, without risk to health or safety applications.

It is a formidable task to apply the essential use concept to all use cases of PFASs in detail.
We have made a start here by illustrating how the concept can be applied to several use cases
of PFASs, but to have a conclusive assessment for each use case described in this review,
follow-up work may need to be covered in more detail (expanded, subdivided and refined) and
engage relevant stakeholders with the necessary in-depth knowledge, where necessary.
Although here we have focused on PFASs, the concept of essential use can also be applied in
the management of other chemicals, or groups of chemicals, of concern.
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